Lpl Financial LLC Embecta Corp. Transaction History

Lpl Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$12.35 - $19.33 $19,266 - $30,154	-1,560 Reduced 13.0%	10,440 $138,000
Q4 2023 Feb 14, 2024	SELL	$12.87 - $19.09 $22,187 - $32,911	-1,724 Reduced 12.56%	12,000 $227,000
Q3 2023 Nov 13, 2023	BUY	$15.0 - $22.17 $20,010 - $29,574	1,334 Added 10.77%	13,724 $206,000
Q2 2023 Jul 31, 2023	SELL	$21.6 - $30.69 $35,013 - $49,748	-1,621 Reduced 11.57%	12,390 $267,000
Q1 2023 May 10, 2023	BUY	$23.07 - $32.77 $19,263 - $27,362	835 Added 6.34%	14,011 $393,000
Q4 2022 Feb 07, 2023	SELL	$25.29 - $35.48 $47,747 - $66,986	-1,888 Reduced 12.53%	13,176 $333,000
Q3 2022 Nov 14, 2022	SELL	$24.0 - $33.42 $78,504 - $109,316	-3,271 Reduced 17.84%	15,064 $434,000
Q2 2022 Aug 12, 2022	BUY	$24.78 - $33.36 $454,341 - $611,655	18,335 New	18,335 $464,000

403

51.2M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $846M
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.